CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....